APPLIED IMAGING ANNOUNCES FDA CLEARANCE TO MARKET GENETIC PROBE TEST

Applied Imaging has received 510(k) clearance from the FDA to market its automated application for Chromosome X and Chromosome Y analysis in bone marrow transplant patients. Applied Imaging's CytoVision system will utilize this application to enumerate tests that are important indicators in evaluating the viability of opposite-sex bone marrow transplants.

ArriveNet

(http://press.arrivenet.com/bus/article.php/560736.html)